Cargando…
Elongin C (ELOC/TCEB1)-associated von Hippel–Lindau disease
Around 95% of patients with clinical features that meet the diagnostic criteria for von Hippel–Lindau disease (VHL) have a detectable inactivating germline variant in VHL. The VHL protein (pVHL) functions as part of the E3 ubiquitin ligase complex comprising pVHL, elongin C, elongin B, cullin 2 and...
Autores principales: | Andreou, Avgi, Yngvadottir, Bryndis, Bassaganyas, Laia, Clark, Graeme, Martin, Ezequiel, Whitworth, James, Cornish, Alex J, Houlston, Richard S, Rich, Philip, Egan, Catherine, Hodgson, Shirley V, Warren, Anne Y, Snape, Katie, Maher, Eamonn R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402235/ https://www.ncbi.nlm.nih.gov/pubmed/35323939 http://dx.doi.org/10.1093/hmg/ddac066 |
Ejemplares similares
-
Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma cases
por: Yngvadottir, Bryndis, et al.
Publicado: (2022) -
Von Hippel-Lindau Disease
por: Hes, Frederik J, et al.
Publicado: (2005) -
Von Hippel-Lindau Disease and the Eye
por: Karimi, Saeed, et al.
Publicado: (2020) -
Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health service
por: Maher, Eamonn R., et al.
Publicado: (2022) -
Investigation and Management of Apparently Sporadic Central Nervous System Haemangioblastoma for Evidence of Von Hippel–Lindau Disease
por: Furness, Hugh, et al.
Publicado: (2021)